News-Yaohai Biopharmaceutical Co., Ltd.

News

CPHI Milan 2024

Oct 08, 2024

The biggest trade fair for the pharmaceutical industry, CPHI Worldwide, will take place in Milan, Italy, from 8 to 10 October 2024 at the Fiera Milano Exhibition Center. CPHI is known to give a platform for anyone in the industry to create connectio...

FCE COSMETIQUE
Jun 04, 2024
The FCE Cosmetique 2024, a cosmetics exhibition in São Paulo, Brazil, will be held from June 4th to June 6th, 2024. This exhibition is one of the largest and most comprehensive cosmetics industry expos in South America. It provides knowledge ...
Read More
BIO International Convention 2024
Jun 03, 2024
BIO International Convention 2024, Dates: 6/3/2024 - 6/6/2024 Venue: San Diego Convention Center. The BIO exhibition is the world's largest biotechnology event, allowing exhibitors to connect with top executives and influential decision-makers who a...
Read More
CPHI North America 2024
May 07, 2024
The CPHI North American is the only pharmaceutical industry event in the United States that covers the entire industry chain of drug research and development, production, packaging, and more. The exhibition will continue to be held in the heavy indu...
Read More
2024 WORLD VACCINE CONGRESS Washington
Apr 01, 2024
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe. Following a record attendance in 2023 of 3000+ attendees...
Read More
BiotechGate, Online
May 13, 2024
BiotechGate Digital Partnering is an innovative online platform that connects global biopharma or biotech companies and services & solutions providers (like CROs and CDMOs). It provides biopharma, biotech, and CRO & CDMO enterprises with a virtual bo...
Read More
DNA Vaccine Production Scale-up Strategies
Oct 14, 2024
Since the initial demonstration of gene expression in vivo through naked DNA injection, DNA vaccines, and gene therapies have advanced significantly. Plasmid DNA is used in both approaches to treat diseases by inducing protein expression. In comparis...
Read More
Nanobodies Meet CAR-T: Shaping the Future of Cancer Therapy
Oct 10, 2024
Chimeric Antigen Receptor T-cell (CAR-T) therapy is an emerging cellular immunotherapy that genetically modifies T-cells to express Chimeric Antigen Receptors (CARs) on their surfaces. These receptors enable T-cells to recognize and specifically targ...
Read More
The Manufacturing Process and Applications of Nanobody
Oct 09, 2024
By targeting specific viruses or structures, engineered antibodies can potentially treat certain high-risk populations. However, similar to monoclonal antibodies, their widespread application is hindered by the high production costs and their large s...
Read More
Plasmid DNA: The Key to Unlocking Cancer's Therapy Code
Sep 27, 2024
Recently, gene therapy has showcased the huge potential in cancer treatment. It can introduce exogenous normal genes into human target cells to repair, replace, or modulate genes within the patient, ultimately achieving therapeutic goals at the ...
Read More
Polypeptides Drugs: The Future of Biomedicine
Sep 26, 2024
The market for polypeptide drugs is experiencing rapid growth in the biomedical sector, with an annual compound growth rate of 8.5% globally from 2020 to 2030, expected to reach US$141.8 billion by 2030. Polypeptide drugs are produced via methods lik...
Read More
Yeast: Key Player in VLP Vaccine for Polio
Sep 25, 2024
Poliomyelitis (polio) is caused by a virus, with symptoms including fever, upper respiratory discomfort, and limb paralysis. The disease is preventable but difficult to cure, and can easily lead to lifelong disability or even death. Thus, vaccines ar...
Read More
Marvelous Fermentation Rate Control Strategies
Sep 24, 2024
Microbial fermentation rate control aims to optimize growth conditions by precisely adjusting key factors such as temperature, pH, dissolved oxygen, and substrate concentration, ensuring that microorganisms are in their optimal physiological state. T...
Read More
Pet's Dedicated Insulin Solution for a Sweet Life
Sep 23, 2024
Diabetes mellitus (DM) is a prevalent disease that affects not only humans but also our beloved pets. As pets' diets improve, their chances of developing diabetes increase due to higher rates of obesity. Based on the database encompassing 2.5 million...
Read More
Harnessing the Power of Fed-batch Fermentation Strategy
Sep 20, 2024
Pichia pastoris is widely used in the production of various heterologous proteins. The High-Cell-Density Fermentation (HCDF) technology, implemented through Fed-Batch feeding, has successfully achieved large-scale production of biopharmaceuticals and...
Read More
Conquering Hepatitis B with Yaohai
Sep 19, 2024
The World Health Organization (WHO) reports that annually, 1.5 million new cases of chronic hepatitis B infection emerge, affecting 296 million individuals globally. Hepatitis B is the disease that causes the most deaths after COVID-19. Therefore, we...
Read More
Comparative Analysis of Yeast and E. coli in Release Testing
Sep 18, 2024
In the field of biopharmaceuticals, Escherichia coli (E. coli) and yeast are two widely used microbial expression systems that have addressed significant challenges such as industrialization and batch-to-batch stability of biological products. Levera...
Read More
Do You Know the Groundbreaking Advancement in Insulin Technology?
Sep 14, 2024
Recombinant human insulin is a paradigmatic case of the mass production of genetically engineered drugs and a crucial application for microbial expression. Since its discovery a century ago, insulin medications have undergone continuous advancements,...
Read More
The Application of VLPs in Human and Veterinary Vaccines
Sep 13, 2024
Last week, we briefly introduced the features, mechanisms of action (MoA), and expression systems of VLPs (Virus-like Particles). VLPs are viral structural proteins that do not contain viral genetic material. Besides, their advantages include nanosca...
Read More
VLPs and Its Manufacturing Process
Sep 12, 2024
Virus-like Particles (VLPs) are unique biomaterials that have similar structures to viruses but essentially do not contain viral genetic material such as DNA or RNA. Therefore, VLPs wouldn't lead to infections in the human body. Due to this character...
Read More